Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Gastroenterology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Gastroparesis Clinical Trials

A listing of Gastroparesis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (26) clinical trials

Learn more about a clinical research study for this condition. Wake Research is enrolling volunteers in a research study testing the safety and effectiveness of an investigational drug for individuals with Gastroparesis. To qualify, you must: Be at least 18 years old Be diagnosed with or have symptoms of Gastroparesis …

Phase N/A

Living with Gastroparesis? Learn more about a clinical research study for this condition. ClinSearch is enrolling volunteers in a research study testing the safety and effectiveness of an investigational drug for individuals with Gastroparesis. To qualify, you must: Be at least 18 years old Be diagnosed with or have symptoms …

Phase N/A

GI Neuromuscular Pathology Prospective Registry

Biopsies will be collected from patients that have been diagnosed with gastroparesis (having nausea, retching, bloating and fullness of stomach) and are undergoing surgery for the GES implantation. These patients will serve as our study group population. Biopsy samples of those who do not have gastroparesis but are undergoing surgery …

Phase N/A

Endoscopic Pyloromyotomy for Refractory Gastroparesis

Gastroparesis is a disorder triggered by numerous causes and it is defined by symptoms and with an objective evidence of delayed gastric emptying in the absence of obstruction (albeit pyloric spasms may play a role in a subset of patients). Gastroparesis may be a consequence of medication, surgery or diabetes …

Phase N/A

The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms

The primary objective of this study is to prescribe oral domperidone for patients with upper GI symptoms who have failed or suffered adverse effects from standard medical therapy

Phase N/A

Domperidone in Treating Patients With Gastrointestinal Disorders

PRIMARY OBJECTIVES: I. To provide treatment with domperidone to patients >= 16 years of age where, according to the investigators' judgment, a prokinetic effect is needed for the relief of gastrointestinal (GI) motility disorders. OUTLINE Patients receive domperidone orally (PO) thrice daily (TID) or four times daily (QID). Treatment continues …

Phase

Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes

This is a randomized controlled trial being conducted at the Universiti Kebangsaan Malaysia Medical Center (UKMMC) with two arms; the control and treatment arms. The treatment arm will receive intravenous human albumin intraoperatively whilst the control arm will receive standard intraoperative fluid regimes. Primary endpoint will be overall complication rates …

Phase

Gastric Per-Oral Endoscopic Myotomy (G-POEM) for the Treatment of Gastroparesis

Gastroparesis is a disease of the stomach where there is significant delay in gastric emptying of contents to the intestines. This disease results in a multitude of symptoms including nausea, vomiting, weight loss, and malnutrition. Current treatments for gastroparesis include dietary changes, oral medications (prokinetic agents to enhance gastric motility, …

Phase N/A

Buspirone for Early Satiety and Symptoms of Gastroparesis

This is a multi-center, randomized, double-masked, placebo-controlled, parallel treatment groups phase 2 trial to determine the effect of buspirone, a 5-hydroxytryptamine (5-HT) 1a receptor agonist, on early satiety and postprandial fullness in participants with symptoms of gastroparesis and with at least moderately severe symptoms of early satiety and/or postprandial fullness. …

Phase

Gastroparesis Registry 3

GpR 3 is an observational study of patients with symptoms of gastroparesis with either delayed or normal gastric emptying. Epidemiological, clinical, physiological, and patient outcome data will be collected to characterize the patients and their clinical course to better understand this disorder. The long-term goal is to help phenotype patients …

Phase N/A